CSBR — Champions Oncology Cashflow Statement
0.000.00%
Last trade - 00:00
- $67.97m
- $63.50m
- $53.87m
- 62
- 49
- 22
- 40
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.128 | -1.98 | 0.362 | 0.548 | -5.33 |
Depreciation | |||||
Non-Cash Items | 1.11 | 1.56 | 0.97 | 1.99 | 2.82 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.018 | 2.49 | -4.2 | 2.34 | 4.24 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 1.86 | 2.9 | -1.68 | 6.5 | 3.97 |
Capital Expenditures | -0.834 | -2.22 | -3.28 | -2.38 | -2.87 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | — | 0.112 | 0 | — |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.834 | -2.22 | -3.17 | -2.38 | -2.87 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.2 | 4.42 | 1.2 | 0.207 | 0.011 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.23 | 5.11 | -3.65 | 4.32 | 1.11 |